Post-DMARDS: Market Dynamics Tracker for RA/AS/PSA
Save time and investment on Post-DMARDs research in Korea by accessing Kantar's latest syndicated report.

Want to learn more?

Overview

Kantar's Post-DMARDs Market Dynamics Tracker for Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) delivers monthly market information that enables companies to make effective marketing decisions for the rapidly changing RA/AS/PsA market.

Key features

Faster information, one platform

Get up-to-date disease specific (RA/AS/PSA) Rx dynamics data. Get faster information compared to existing secondary data.

Detailed market information

Monitor patient potential and TX dynamics with smaller market segment - naive/switching post - DMARDS market (biologics/TT).

Establish counter strategies

Understand the correlation between market issues (intro of new agent, change of reimbursement guideline, etc.) and physician's Rx pattern change.

Related solutions
Digital Physician and Patient Life 2018 assesses where physicians and patients are spending their time in the digital environment.
Syndicated studies provide analysis of real-world prescription patterns and competitive intelligence for many diseases.
Identify and screen oncology development targets with breakthrough potential quickly, comprehensively and accurately.